Please login to the form below

Not currently logged in
Email:
Password:

Orion appoints VP of oncology, R&D

Professor Heikki Joensuu joins from Helsinki University Hospital

Finnish pharmaceutical group, Orion has appointed its new vice president of oncology, research and development, in the form of professor Heikki Joensuu.

He said: “My new position at Orion allows me to maintain and deepen my research focus, which is to develop such treatments for cancer patients wherever they live.

“I hope that my long background in the academia will help in the initiation of new research projects between Orion and the academia.

“Such collaboration will likely benefit all stakeholders, including the society and, most importantly, the patients."

Previously, Joensuu served at Helsinki University Hospital, where he worked as the research director from 2015-2017 in its comprehensive cancer centre.

Prior to that, he was research professor of the Academy of Finland from 2010-2014.

Christer Nordstedt, senior vice president, R&D, Orion, said: “This appointment is an excellent step to further the co-operation of Helsinki University Hospital and Orion boosts our relationship.

“I am also happy that such a top researcher from the academic society joins Orion – in the past few years several of our colleagues have left the company to top positions in the universities and public sector.

“This cross fertilisation between the public and private sectors is very likely to be beneficial for the scientific and public communities.”

15th November 2017

From: Research

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

How ‘Greenwashing’ accusations could delay the very changes its supporters demand
Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...
What does the future hold for clinical trial recruitment?
The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...
When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...